Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis

a Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia b Department of Cardiology B, Oslo University Hospital Ulleval, 0407 Oslo, Norway c Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway d Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, VIC 3068 Australia e Novartis Pharmaceuticals Corp., Development Franchise — Critical Care, East Hanover, USA f Novartis Pharma DS&E and Oncology, Drug Safety and Epidemiology, Basel, Switzerland